Sign in

CIK 0001528172 · Non-accelerated filer<br>Smaller reporting company

ENDONOVO THERAPEUTICS, INC.

Sign in to watch
Ticker
ENDV
Exchange
OTC
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
452552528
Phone
(800) 489-4774
Business address
6320 CANOGA AVENUE, 15TH FLOOR, WOODLAND HILLS, CA, 91367
Former names
Hanover Portfolio Acquisitions, Inc.
  1. 4 Open-market buy President bought 12,000 shares at an average $0.11 ($1,268)
  2. 4 Open-market buy President bought 29,000 shares at an average $0.05 ($1,549)
  3. 4 Open-market buy President bought 11,000 shares at an average $0.06 ($612)
  4. 4 Open-market buy President bought 32,000 shares at an average $0.05 ($1,724)
  5. 10-K Report Annual Report
  6. 4 Open-market buy President bought 13,000 shares at an average $0.06 ($836)
  7. 4 Open-market buy President bought 29,000 shares at an average $0.08 ($2,296)
  8. 4/A Open-market buy President bought 30,000 shares at an average $0.09 ($2,554)
  9. 4 Open-market buy President bought 3,000 shares at $0.09 ($267)
  10. 4 Open-market buy President bought 20,089,849 shares at an average $0.09 ($1,866,113)
  11. 4 Open-market buy President bought 27,000 shares at an average $0.10 ($2,681)
  12. 4 Open-market buy President bought 19,500 shares at an average $0.07 ($1,425)
  13. 4 Open-market buy President bought 18,000 shares at an average $0.06 ($1,056)
  14. 4 Open-market buy President bought 51,100 shares at an average $0.05 ($2,309)
  15. NT 10-K Other NT 10-K
  16. 4 Open-market buy President bought 39,400 shares at an average $0.04 ($1,690)
  17. SC 13G Stake Amended Statement of Ownership
  18. 4 Open-market buy President bought 9,000 shares at an average $0.05 ($449)
  19. 4 Open-market buy President bought 31,200 shares at an average $0.05 ($1,669)
  20. 4 Open-market buy President bought 9,000 shares at an average $0.05 ($483)

Page 19 of 26 · 502 filings